De Backer, J.; Maric, D.; Zuhra, K.; Bogaerts, A.; Szabo, C.; Vanden Berghe, W.; Hoogewijs, D.
Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response. Antioxidants 2022, 11, 1548.
https://doi.org/10.3390/antiox11081548
AMA Style
De Backer J, Maric D, Zuhra K, Bogaerts A, Szabo C, Vanden Berghe W, Hoogewijs D.
Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response. Antioxidants. 2022; 11(8):1548.
https://doi.org/10.3390/antiox11081548
Chicago/Turabian Style
De Backer, Joey, Darko Maric, Karim Zuhra, Annemie Bogaerts, Csaba Szabo, Wim Vanden Berghe, and David Hoogewijs.
2022. "Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response" Antioxidants 11, no. 8: 1548.
https://doi.org/10.3390/antiox11081548
APA Style
De Backer, J., Maric, D., Zuhra, K., Bogaerts, A., Szabo, C., Vanden Berghe, W., & Hoogewijs, D.
(2022). Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response. Antioxidants, 11(8), 1548.
https://doi.org/10.3390/antiox11081548